Cynosure Group’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,165
Closed -$581K 404
2025
Q3
$581K Hold
7,165
0.06% 139
2025
Q2
$449K Buy
7,165
+2,457
+52% +$145K 0.05% 212
2025
Q1
$339K Buy
4,708
+1,335
+40% +$109K 0.05% 266
2024
Q4
$290K Sell
3,373
-740
-18% -$73.7K 0.04% 297
2024
Q3
$390K Sell
4,113
-3,018
-42% -$268K 0.06% 224
2024
Q2
$681K Buy
7,131
+1,902
+36% +$226K 0.11% 135
2024
Q1
$689K Buy
+5,229
New +$644K 0.12% 91

Other funds holding ALB

Cynosure Group's ALB Position: Q4 2025 in Review

Cynosure Group sold out of Albemarle (ALB) in Q4 2025, closing a stake of 7,165 shares — an estimated $581K sold.

Cynosure Group first reported a position in ALB in Q1 2024 and held it in 7 quarters. The position peaked at $689K in Q1 2024. 908 funds tracked by Wall St. Rank hold ALB as of Q4 2025.

  • Cynosure Group reported no remaining Albemarle position as of Q4 2025 after selling out during the quarter.
  • Cynosure Group sold 7,165 Albemarle shares in Q4 2025, an estimated $581K.
  • Cynosure Group first reported a position in Albemarle in Q1 2024 and held it in 7 quarters.
  • Cynosure Group's Albemarle position peaked at $689K in Q1 2024.
  • 908 funds tracked by Wall St. Rank held Albemarle as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.